% | $
Quotes you view appear here for quick access.

Titan Medical Inc. Message Board

  • cuin2 cuin2 Mar 11, 2014 6:05 PM Flag

    Big News Release!!!

    TORONTO, ONTARIO--(Marketwired - March 11, 2014) - Titan Medical Inc.(TITXF) ("Titan" or the "Company") (OTCQX:TITXF) is pleased to announce that Dr. Bruce Giles Wolff, M. D., Professor of Surgery, Mayo Clinic College of Medicine and Emeritus Chair of the Division of Colon & Rectal Surgery, Mayo Clinic - Rochester, Minn., has been appointed to the Board of Directors. Dr. Wolff has been a member of the Mayo Clinic's Surgical Administrative Committee since 2006. Dr. Wolff is a former President of the American Society of Colon and Rectal Surgeons, a former Director and President of the American Board of Colon and Rectal Surgery, and a former Vice President and Director of the Foundation for Surgical Fellowships. Dr. Wolff has written extensively on colon and rectal surgery issues in almost 300 articles for publications such as The American Journal of Surgery, the Canadian Journal of Surgery, the World Journal of Surgery, Mayo Clinic Proceedings, the America Surgeon, the Journal of Gastrointestinal Surgery, Diseases of the Colon & Rectum, Annals of Surgery and the British Journal of Surgery.

    Dr. Wolff received his M.D. from Duke University School of Medicine and interned and completed his residency at the New York Hospital Cornell Medical Centre. He received a fellowship from the Mayo Clinic in 1981-82 and since then he has taught and practiced medicine at the Mayo Clinic.

    "I am delighted that such a renowned medical professional such as Dr. Wolff has agreed to be a Director on Titan's Board of Directors. He has a wealth of expertise and experience in the colon and rectal surgery field which will be of great benefit to Titan" stated Titan CEO John Hargrove.

    About Titan Medical Inc.(TITXF)

    Titan Medical Inc. (TITXF) is a Canadian public company focused on the design and development of a robotic surgical system for application in minimally invasive surgery ("MIS"). The Company's Single Port Orifice Robotic Technology, SPORT(TM) Surgical System, currently under development, comprises a surgeon-controlled robotic platform that includes a 3D vision system and interactive instruments for performing MIS procedures, and a surgeon workstation that provides the surgeon with an interface to the robotic platform for controlling the interactive instruments and providing a 3D endoscopic view of inside a patient's body during MIS procedures. The SPORT(TM) Surgical System is being designed to expand robotic surgery into areas of surgical specialties and simple and complex procedures that are currently under-serviced, and to allow surgeons to perform procedures within small to medium size surgical spaces such as general surgery and cholecystectomy. For more information, visit the Company's website at

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.04+0.01(+0.97%)10:04 AMEDT